Liver fibrosis in 2015: Crucial steps towards an effective treatment

Nature Reviews Gastroenterology and Hepatology

Volumn 13, Issue 2, 2016, Pages 67-68

  Poelstra, Klaas ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MICRORNA; MICRORNA 130A 3P; MICRORNA 142 5P; NUCLEAR RECEPTOR 4 A1; RECEPTOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; CELL ACTIVATION; CELL ACTIVITY; CELL POLARITY; DISEASE COURSE; FIBROBLAST; FIBROGENESIS; HUMAN; LIVER FIBROSIS; MACROPHAGE FUNCTION; MICROBIOME; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SHORT SURVEY; STELLATE CELL; LIVER CIRRHOSIS; MACROPHAGE; PHYSIOLOGY;

HUMANS; LIVER CIRRHOSIS; MACROPHAGES;

EID: 84956753811     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.224     Document Type: Short Survey

References (10)

1. Palumbo-Zerr, K. et al. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis. Nat. Med. 21, 150-158 (2015).
2. Kantari-Mimoun, C. et al. Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis. Hepatology 61, 2042-2055 (2015).
3. Pellicoro, A. et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 14, 181-194 (2014).
4. Su, S. et al. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat. Commmun. 6, 8523 (2015).
5. Calvente, C. J. et al. Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis. Hepatology 62, 1285-1297 (2015).
6. Torok, N. J. et al. Strategies and endpoints of antifibrotic drug trials: summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology 62, 627-634 (2015).
7. Bajaj, J. S. et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 62, 1260-1271 (2015).
8. Bajaj, J. S., Betrapally, N. S. & Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature 525, E1-E3 (2015).
9. Szabo, G. Gut-liver axis in alcoholic liver disease. Gastroenterology 148, 30-36 (2015).
10. Karimi-Shah, B. A. & Chowdhury, B. A. Forced vital capacity in idiopathic pulmonary fibrosis-FDA review of pirfenidone and nintedanib. N. Engl. J. Med. 372, 1189-1191 (2015).